Study analyzes the average inpatient care costs for COVID-19 patients, revealing significant variations in expenses across pandemic waves and patient demographics.
Setting up a showdown with Boehringer, Pfizer scores interchangeability tag for its Humira biosimilar
Beginning later this month, Pfizer is launching an interchangeable biosimilar to AbbVie’s blockbuster rheumatoid arthritis drug Humira (adalimumab) at a 5% discount on the wholesale
October 10, 2023